INFARCT HETEROGENEITY IS AN INDEPENDENT AND INCREMENTAL PREDICTOR OF MORTALITY IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY  by Asamoto, Lisa et al.
Imaging
E1066
JACC March 27, 2012
Volume 59, Issue 13
INFARCT HETEROGENEITY IS AN INDEPENDENT AND INCREMENTAL PREDICTOR OF MORTALITY IN 
PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY
ACC Oral Contributions
McCormick Place South, S403
Saturday, March 24, 2012, 8:30 a.m.-8:45 a.m.
Session Title: A Better Understanding of Ischemia and Function: Insights from Cardiac MRI
Abstract Category: 21. Imaging: MRI
Presentation Number: 908-5
Authors: Lisa Asamoto, Rory Hachamovitch, Zoran Popovic, Randall Starling, Scott Flamm, Thomas Marwick, Deborah Kwon, Cleveland Clinic, 
Cleveland, OH, USA
Background:  Previous studies have demonstrated that infarct heterogeneity (IH) is a predictor of ventricular tachycardia and post myocardial 
infarction death. It is unknown if IH is an independent predictor of mortality in patients with ICM and severe left ventricular (LV) dysfunction. 
Methods:  450 pts with ICM (LV ejection fraction < 40%, with >70% stenosis in ≥1 epicardial coronary artery) underwent delayed 
hyperenhancement-MRI (Avanto, Siemens) between 2002-2006. Total infarct size was defined as ≥ 2SD brighter than remote myocardium. Core and 
peri-infarct regions were identified based on signal-intensity thresholds (>3 SDs for core infarct and 2-3 SD for peri-infarct zone). IH was expressed 
as a percentage: peri-infarct mass/left ventricular mass.
Results:  The mean LVEF was 23 ± 9%, mean ESVi 115 ± 50 ml, mean total scar was 30 ± 14%, and mean IH was 6 ± 4%. 186 deaths 
occurred over a mean 5.8y follow-up. Quantification of IH (r2 11.4, p = <0.001) was an independent predictor of survival, independent of age, 
revascularization, gender, mitral valve procedures, ICD implantation, indexed ESV (ESVi) (r2 16.4, p=0.006) and total scar % (r2 18.3, p = <0.001). 
Higher percentage of IH added incrementally to risk with increasing higher ESVI (Fig 1).
Conclusions:  In severe ICM, IH is an independent and incremental predictor of all-cause mortality in patients with ICM and severe LV dysfunction.
